Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manmeet Singh Ahluwalia

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancers|December 17, 2024
Evaluating the Safety of Immune Checkpoint Inhibitors and Combination Therapies in the Management of Brain Metastases: A Comprehensive ReviewVivek Podder, Tulika Ranjan, Kim Margolin, et al.
Cancers|October 16, 2024
Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future DirectionsTulika Ranjan, Vivek Podder, Kim Margolin, et al.
Targeted Oncology|November 2, 2025
The Efficacy and Safety of Beta-blockers and Immune Checkpoint Inhibitors in Patients with Cancer: A Systematic Review and Meta-analysisKota Tokunaga, Yu Fujiwara, Reo Omori, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2025
Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxMHenry G Withers, Sheila A Figel, Jingxin Qiu, et al.
Neuro-Oncology|October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2025
Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS studyMinesh P Mehta, Vinai Gondi, Manmeet Singh Ahluwalia, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancers|December 17, 2024
Evaluating the Safety of Immune Checkpoint Inhibitors and Combination Therapies in the Management of Brain Metastases: A Comprehensive ReviewVivek Podder, Tulika Ranjan, Kim Margolin, et al.
Cancers|October 16, 2024
Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future DirectionsTulika Ranjan, Vivek Podder, Kim Margolin, et al.
Targeted Oncology|November 2, 2025
The Efficacy and Safety of Beta-blockers and Immune Checkpoint Inhibitors in Patients with Cancer: A Systematic Review and Meta-analysisKota Tokunaga, Yu Fujiwara, Reo Omori, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2025
Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxMHenry G Withers, Sheila A Figel, Jingxin Qiu, et al.
Neuro-Oncology|October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2025
Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS studyMinesh P Mehta, Vinai Gondi, Manmeet Singh Ahluwalia, et al.
Pageof 1